{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "ANF",
      "CYP1A1",
      "CYP1A2",
      "CYP1B1",
      "cancer",
      "cancer's pathogenesis"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36655529",
  "DateCompleted": {
    "Year": "2023",
    "Month": "06",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "06",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2174/1871520623666230119103914"
    ],
    "Journal": {
      "ISSN": "1875-5992",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "9",
        "PubDate": {
          "Year": "2023"
        }
      },
      "Title": "Anti-cancer agents in medicinal chemistry",
      "ISOAbbreviation": "Anticancer Agents Med Chem"
    },
    "ArticleTitle": "CYP1B1: A Promising Target in Cancer Drug Discovery.",
    "Pagination": {
      "StartPage": "981",
      "EndPage": "988",
      "MedlinePgn": "981-988"
    },
    "Abstract": {
      "AbstractText": [
        "CYP1B1 plays an essential role in cancer's pathogenesis since it activates procarcinogens. Significantly, this enzyme catalyzes the hydroxylation of 17\u03b2-estradiol, leading to carcinogenic metabolites involved in carcinogenesis and cancer progression. Therefore, the inhibition of CYP1B1 activity is considered a therapeutic target for chemotherapy. In addition, CYP1B1 is overexpressed in hormone-dependent cancer cells and could be related to resistance to anticancer drugs. However, the activity of CYP1B1 in the tumor microenvironment can metabolize and activate prodrugs in cancer cells, providing more selectivity and being useful for chemoprevention or chemotherapy strategies. Furthermore, due to its importance in anticancer drug design, recent studies have reported using computational methods to understand the intermolecular interactions between possible ligands and CYP1B1. Therefore, in this perspective, we highlight recent findings in developing CYP1B1 inhibitors (flavonoids, trans-stilbenes, estradiol derivatives, and carbazoles) and CYP1B1-activated prodrugs (a chalcone DMU-135 and an oxime DMAKO-20). Finally, we have analyzed their possible molecular interactions with this enzymatic target by molecular docking, which can help to design new active substances."
      ],
      "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departamento de Qu\u00edmica, Laborat\u00f3rio de S\u00edntese de Mol\u00e9culas Medicinais (LaSMMed), Centro de Ci\u00eancias Exatas, Universidade Estadual de Londrina, Londrina, Brazil."
          }
        ],
        "LastName": "Fabris",
        "ForeName": "Marci\u00e9li",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departamento de Qu\u00edmica, Laborat\u00f3rio de S\u00edntese de Mol\u00e9culas Medicinais (LaSMMed), Centro de Ci\u00eancias Exatas, Universidade Estadual de Londrina, Londrina, Brazil."
          }
        ],
        "LastName": "Luiza Silva",
        "ForeName": "Mariana",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departamento de Qu\u00edmica, Laborat\u00f3rio de S\u00edntese de Mol\u00e9culas Medicinais (LaSMMed), Centro de Ci\u00eancias Exatas, Universidade Estadual de Londrina, Londrina, Brazil."
          }
        ],
        "LastName": "de Santiago-Silva",
        "ForeName": "Kaio Maciel",
        "Initials": "KM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departamento de Qu\u00edmica, Laborat\u00f3rio de S\u00edntese de Mol\u00e9culas Medicinais (LaSMMed), Centro de Ci\u00eancias Exatas, Universidade Estadual de Londrina, Londrina, Brazil."
          }
        ],
        "LastName": "de Lima Ferreira Bispo",
        "ForeName": "Marcelle",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Departamento de Qu\u00edmica, Laborat\u00f3rio de S\u00edntese de Mol\u00e9culas Medicinais (LaSMMed), Centro de Ci\u00eancias Exatas, Universidade Estadual de Londrina, Londrina, Brazil."
          }
        ],
        "LastName": "Goes Camargo",
        "ForeName": "Priscila",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Anticancer Agents Med Chem",
    "NlmUniqueID": "101265649",
    "ISSNLinking": "1871-5206"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 1.14.14.1",
      "NameOfSubstance": "Cytochrome P-450 CYP1A1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prodrugs"
    },
    {
      "RegistryNumber": "EC 1.14.14.1",
      "NameOfSubstance": "Cytochrome P-450 CYP1B1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "4TI98Z838E",
      "NameOfSubstance": "Estradiol"
    },
    {
      "RegistryNumber": "EC 1.14.14.1",
      "NameOfSubstance": "CYP1B1 protein, human"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Cytochrome P-450 CYP1A1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Docking Simulation"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Prodrugs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cytochrome P-450 CYP1B1"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Discovery"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Estradiol"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tumor Microenvironment"
    }
  ]
}